Companies

Xeris Biopharma Holdings, Inc. (XERS) SEC filings

CIK 0001867096 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2021
Revenue (USD)291.8 M110.2 M
Net income (USD)-91.1 M
Diluted EPS (USD/shares)0-0.7

Latest filings

FiledFormDescriptionPeriod
2026-10-148-K8-K items 8.012026-10-13
2026-10-024FORM 42026-10-01
2026-10-024FORM 42026-10-01
2026-10-024FORM 42026-10-01
2026-10-01144144
2026-09-294FORM 42026-09-28
2026-09-28144144
2026-09-098-K8-K items 7.01,9.012026-09-09
2026-09-014FORM 42026-09-01
2026-09-014FORM 42026-09-01
2026-09-014FORM 42026-09-01
2026-08-214FORM 42026-08-01
2026-08-214FORM 42026-08-01
2026-08-124FORM 42026-08-12
2026-08-12144144
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-08-044FORM 42026-08-03
2026-08-044FORM 42026-08-03
2026-07-31SCHEDULE 13GSCHEDULE 13G
2026-07-178-K8-K items 3.02,8.012026-07-15
2026-07-074FORM 42026-07-06
2026-07-07144144
2026-07-06144144
2026-07-024FORM 42026-07-01

Forms on file (last 1,000): 4 152, 8-K 56, 144 24, 3 18, 10-Q 15, S-8 7, UPLOAD 7, DEFA14A 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=XERS (0.002 USD), /gw/filings/filings?ticker=XERS&form=8-K, /gw/filings/facts?ticker=XERS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange